FDA Inspection 1246994 — Tianjin Kingyork Pharmaceuticals Co., Ltd
The FDA completed an inspection of Tianjin Kingyork Pharmaceuticals Co., Ltd on July 26, 2024 in Tianjin Economic Tech. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianjin Economic Tech (China)